This article has been corrected to note that the mean coverage was 391 times, not 102 times as cited in the original article.

By Andrea Anderson

CHICAGO (GenomeWeb News) – A team of researchers led by investigators at the Dana-Farber Cancer Institute have developed a massively-parallel sequencing strategy for profiling "actionable" cancer genes from formalin-fixed paraffin-embedded tumor samples, Dana-Farber oncologist Nikhil Wagle reported at the American Society of Clinical Oncology annual meeting.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Oxford researchers are turning to virtual reality to visualize genes and regulatory elements, Phys.org says.

The Jackson Laboratory has filed a complaint accusing Nanjing University of breeding and re-selling its mouse models, the Hartford Courant reports.

In Science this week: neutrophils rely on microRNA to protect against lung inflammation, and more.

China is moving forward with plans to sequence a million citizens, the Wall Street Journal reports.

Sep
27
Sponsored by
Philips Genomics

This webinar will present an in-depth look at how Memorial Sloan Kettering Cancer Center has developed and implemented a next-generation sequencing panel for mutational tumor profiling of advanced cancer patients.

Sep
28
Sponsored by
Fabric Genomics

This webinar will discuss the critical role that software can play for clinical labs looking to establish comprehensive genomic testing programs.